Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 280

Similar articles for PubMed (Select 15795889)

1.

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort.

Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, Lok AS.

Hepatology. 2005 Apr;41(4):707-16.

PMID:
15795889
2.

Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.

Abbas Z, Siddiqui AU, Luck NH, Hassan M, Mirza R, Naqvi A, Rizvi AH.

J Pak Med Assoc. 2008 Nov;58(11):602-7.

PMID:
19024130
3.

Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems.

Giannini E, Risso D, Botta F, Romagnoli P, Malfatti F, Fumagalli A, Testa E, Podestà E, Chiarbonello B, Polegato S, Testa R.

J Intern Med. 2004 Mar;255(3):399-408.

PMID:
14871465
4.

Prospective validation of the Barcelona Clinic Liver Cancer staging system.

Cillo U, Vitale A, Grigoletto F, Farinati F, Brolese A, Zanus G, Neri D, Boccagni P, Srsen N, D'Amico F, Ciarleglio FA, Bridda A, D'Amico DF.

J Hepatol. 2006 Apr;44(4):723-31. Epub 2006 Jan 24.

PMID:
16488051
6.

Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems.

Cammà C, Di Marco V, Cabibbo G, Latteri F, Sandonato L, Parisi P, Enea M, Attanasio M, Galia M, Alessi N, Licata A, Latteri MA, Craxì A.

Aliment Pharmacol Ther. 2008 Jul;28(1):62-75. doi: 10.1111/j.1365-2036.2008.03692.x. Epub 2008 Mar 27.

PMID:
18373636
7.

Comparison of staging systems to predict survival in hepatocellular carcinoma.

Pascual S, Zapater P, Such J, García-Herola A, Sempere L, Irurzun J, Palazón JM, Carnicer F, Pérez-Mateo M.

Liver Int. 2006 Aug;26(6):673-9.

PMID:
16842323
8.

Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

Cho YK, Chung JW, Kim JK, Ahn YS, Kim MY, Park YO, Kim WT, Byun JH.

Cancer. 2008 Jan 15;112(2):352-61.

9.

Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score.

Chung H, Kudo M, Takahashi S, Hagiwara S, Sakaguchi Y, Inoue T, Minami Y, Ueshima K, Fukunaga T, Matsunaga T.

J Gastroenterol Hepatol. 2008 Mar;23(3):445-52. Epub 2007 Aug 6.

PMID:
17683486
11.

[Modified CLIP score as a new prognostic index for patients with hepatocellular carcinoma].

Han SH, Han SY, Go BS, Kim MJ, Lee JH, Koo YH, Ryu SH, Cho JH, Jang JS, Lee JH, Roh MH, Choi SR, Choi JC, Lee SW.

Korean J Hepatol. 2006 Jun;12(2):209-20. Korean.

12.

Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models.

Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Lee PC, Loong CC, Chiang JH, Huo TI, Lee SD.

Cancer. 2010 Jun 15;116(12):3006-14. doi: 10.1002/cncr.25044.

13.

The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?

Cillo U, Bassanello M, Vitale A, Grigoletto FA, Burra P, Fagiuoli S, D'Amico F, Ciarleglio FA, Boccagni P, Brolese A, Zanus G, D'Amico DF.

J Hepatol. 2004 Jan;40(1):124-31.

PMID:
14672623
14.

Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.

Huo TI, Hsia CY, Huang YH, Lin HC, Lee PC, Lui WY, Chiang JH, Chiou YY, Loong CC, Lee SD.

J Clin Gastroenterol. 2009 Sep;43(8):773-81. doi: 10.1097/MCG.0b013e31818dd962.

PMID:
19262404
15.

Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.

Guglielmi A, Ruzzenente A, Pachera S, Valdegamberi A, Sandri M, D'Onofrio M, Iacono C.

Am J Gastroenterol. 2008 Mar;103(3):597-604. Epub 2007 Oct 26.

PMID:
17970836
16.

Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis.

Takizawa D, Kakizaki S, Sohara N, Sato K, Takagi H, Arai H, Katakai K, Kojima A, Matsuzaki Y, Mori M.

Dig Dis Sci. 2007 Nov;52(11):3290-5. Epub 2007 Mar 30.

PMID:
17394062
17.

Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI.

Lu W, Dong J, Huang Z, Guo D, Liu Y, Shi S.

J Gastroenterol Hepatol. 2008 Dec;23(12):1874-8. doi: 10.1111/j.1440-1746.2008.05527.x.

PMID:
18752560
18.

Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.

Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G.

Am J Gastroenterol. 2005 Dec;100(12):2708-16.

PMID:
16393224
19.

Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.

Vauthey JN, Ribero D, Abdalla EK, Jonas S, Bharat A, Schumacher G, Lerut J, Chapman WC, Hemming AW, Neuhaus P.

J Am Coll Surg. 2007 May;204(5):1016-27; discussion 1027-8.

PMID:
17481532
20.

Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method--analysis of 2010 Taiwanese patients.

Chen CH, Hu FC, Huang GT, Lee PH, Tsang YM, Cheng AL, Chen DS, Wang JD, Sheu JC.

Eur J Cancer. 2009 Jun;45(9):1630-9. doi: 10.1016/j.ejca.2008.12.025. Epub 2009 Jan 20.

PMID:
19157858
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk